In one post you claimed the trial was going to cost 30 to 40 million then in another you said it was going to cost 20 to 30 million. So which is it?
Personally, based on the 26k per patient cost reported in the “Clinical Operations: Accelerating Trials, Allocating Resources and Measuring Performance” study, I think you are way off base in either case.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.